Skip to main content

Moban Side Effects

Generic name: molindone

Note: This document contains side effect information about molindone. Some dosage forms listed on this page may not apply to the brand name Moban.

Applies to molindone: oral syrup, oral tablet.

Serious side effects of Moban

Along with its needed effects, molindone (the active ingredient contained in Moban) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking molindone:

More common

Less common


Incidence not known

Other side effects of Moban

Some side effects of molindone may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

Incidence not known

For Healthcare Professionals

Applies to molindone: oral concentrate, oral tablet.


The most common side effects include drowsiness; less frequently occurring side effects include depression, hyperactivity, and euphoria.[Ref]

Nervous system

Akathisia/motor restlessness occurred early in treatment.

Drowsiness occurred with initial treatment and usually subsided with continued use or lowering of the dose.

Extrapyramidal symptoms (EPS) may occur in susceptible patients, but is usually reversible with appropriate therapy; EPS symptoms include akathisia.

Parkinson syndrome occurred less frequently than akathisia and includes rigidity, immobility, and reduction of voluntary movements/tremor.[Ref]

Frequency not reported: Drowsiness, hyperactivity, extrapyramidal symptoms, akathisia/motor restlessness, dystonia, tardive dyskinesia, Parkinson syndrome[Ref]


Frequency not reported: Urinary retention, priapism, amenorrhea, resumption of menses, heavy menses, galactorrhea[Ref]

Urinary retention may occur more frequently during concomitant use with anticholinergic drugs.[Ref]


Frequency not reported: Dry mouth, nausea, salivation, constipation[Ref]

Constipation may occur more frequently during concomitant use with anticholinergic drugs.[Ref]


Rare, transient, nonspecific T wave changes have been reported on ECGs; however, there is no established association with this drug.[Ref]

Frequency not reported: Tachycardia, T wave changes, significant hypotension[Ref]


Frequency not reported: Leukopenia, leukocytosis, alterations in red blood cells[Ref]

Red blood cell alterations were not clinically significant.[Ref]


Frequency not reported: Depression, euphoria, increased libido[Ref]


Frequency not reported: Blood glucose alteration, weight gain/loss (not excessive)[Ref]

Blood glucose alterations were not considered clinically significant.[Ref]


Thyroid function alterations were not clinically significant.[Ref]

Frequency not reported: Alterations in thyroid function, gynecomastia[Ref]


Nonspecific skin rash (likely of allergic origin) occurred early during treatment.

Skin pigmentation did not occur when this drug is used alone.[Ref]

Frequency not reported: Skin rash, skin pigmentation[Ref]


Frequency not reported: Alterations in liver function[Ref]

Liver function alterations have been clinically significant in some patients.[Ref]


Frequency not reported: Alterations in blood urea nitrogen (BUN)[Ref]

BUN alterations were not clinically significant.[Ref]


Frequency not reported: Blurring of vision[Ref]


1. (2001) "Product Information. Moban (molindone)." Gate Pharmaceuticals

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.